U.S. flag

An official website of the United States government

NM_006363.6(SEC23B):c.1588C>T (p.Arg530Trp) AND Congenital dyserythropoietic anemia, type II

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Aug 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000001283.5

Allele description [Variation Report for NM_006363.6(SEC23B):c.1588C>T (p.Arg530Trp)]

NM_006363.6(SEC23B):c.1588C>T (p.Arg530Trp)

Gene:
SEC23B:SEC23 homolog B, COPII coat complex component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20p11.23
Genomic location:
Preferred name:
NM_006363.6(SEC23B):c.1588C>T (p.Arg530Trp)
HGVS:
  • NC_000020.11:g.18543095C>T
  • NG_016281.2:g.40614C>T
  • NM_001172745.3:c.1588C>T
  • NM_001172746.3:c.1534C>T
  • NM_006363.4:c.1588C>T
  • NM_006363.6:c.1588C>TMANE SELECT
  • NM_032985.6:c.1588C>T
  • NM_032986.5:c.1588C>T
  • NP_001166216.1:p.Arg530Trp
  • NP_001166217.1:p.Arg512Trp
  • NP_006354.2:p.Arg530Trp
  • NP_116780.1:p.Arg530Trp
  • NP_116781.1:p.Arg530Trp
  • LRG_1134t1:c.1588C>T
  • LRG_1134:g.40614C>T
  • LRG_1134p1:p.Arg530Trp
  • NC_000020.10:g.18523739C>T
  • NM_001172745.2:c.1588C>T
  • Q15437:p.Arg530Trp
Protein change:
R512W; ARG530TRP
Links:
UniProtKB: Q15437#VAR_062307; OMIM: 610512.0003; dbSNP: rs121918223
NCBI 1000 Genomes Browser:
rs121918223
Molecular consequence:
  • NM_001172745.3:c.1588C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001172746.3:c.1534C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006363.6:c.1588C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_032985.6:c.1588C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_032986.5:c.1588C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital dyserythropoietic anemia, type II (CDAN2)
Synonyms:
Dyserythropoietic anemia, congenital type 2; CDA 2; HEMPAS anemia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009134; MedGen: C1306589; Orphanet: 98873; OMIM: 224100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000021433OMIM
no assertion criteria provided
Pathogenic
(Aug 1, 2009)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV004039080Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Aug 11, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.

Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, Paw BH, Hopfner KP, Holzmann K, Russo R, Esposito MR, Spano D, De Falco L, Heinrich K, Joggerst B, Rojewski MT, Perrotta S, Denecke J, Pannicke U, Delaunay J, Pepperkok R, Heimpel H.

Nat Genet. 2009 Aug;41(8):936-40. doi: 10.1038/ng.405. Epub 2009 Jun 28.

PubMed [citation]
PMID:
19561605

Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II.

Unal S, Russo R, Gumruk F, Kuskonmaz B, Cetin M, Sayli T, Tavil B, Langella C, Iolascon A, Uckan Cetinkaya D.

Pediatr Transplant. 2014 Jun;18(4):E130-3. doi: 10.1111/petr.12254. Epub 2014 Apr 12.

PubMed [citation]
PMID:
24724984

Details of each submission

From OMIM, SCV000021433.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

For discussion of the arg530-to-trp (R530W) mutation in the SEC23B gene that was found in compound heterozygous state in patients with congenital dyserythropoietic anemia type II (CDAN2; 224100) by Schwarz et al. (2009), see 610512.0002.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004039080.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: SEC23B c.1588C>T (p.Arg530Trp) results in a non-conservative amino acid change located in the Sec23/Sec24, helical domain (IPR006900) of the encoded protein sequence. This alters a highly conserved residue in which another missense variant p.Arg530Gln) has been found in association with disease (HGMD). Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251468 control chromosomes (gnomAD). c.1588C>T has been reported in the literature in individuals affected with Congenital dyserythropoietic anemia, type II who were reported as compound heterozygous with other pathogenic variants (Schwarz_2009, Unal_2014). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 19561605, 24724984). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2024